Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3 entry.
    Difference
    0.0%
    Check dated 2026-01-14T03:27:58.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure text and the previous Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:15:31.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Publications section wording updated to clarify that publications are automatically filled from PubMed and may not be about the study, and the revision tag updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:48:31.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The government funding status notice on the page has been removed.
    Difference
    0.3%
    Check dated 2025-11-18T07:14:36.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    No substantive changes detected in the study record; core fields such as title, conditions, interventions, outcomes, eligibility, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:07:07.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Summary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:33:19.000Z thumbnail image

Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.